Yukiya Yamamoto

4PUBLICATIONS
6CO-AUTHORS
Haematological tumoursInfant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 08, 2024
ELC52: a novel megakaryocytic leukemia cell line with a CALR type 1 mutation.

Yukiya Yamamoto, Sachiko Iba, Yoko Inaguma

|Sep 14, 2022
PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development.

Xinhui Zhao, Boris Bartholdy, Yukiya Yamamoto

|Jul 19, 2022
A novel RARA-SNX15 fusion in PML-RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1).

Kentaro Hirade, Shigeru Kusumoto, Akihiro Abe

|Jan 13, 2022
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma.

Akinao Okamoto, Hidetsugu Fujigaki, Chisako Iriyama

Pageof 1